Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00700843 · ClinicalTrials.gov registry record
Long-Term Follow-up of Ohio State University Medical Center (OSUMC) Bariatric Patients
A clinical trial, sponsored by Ohio State University.
- Terminated
- Registry status
- 23
- Enrollment target
NCT00700843: Clinical Trial study, sponsored by Ohio State University.
NCT00700843 is a clinical trial that was terminated before completion, run by Ohio State University. The registered enrollment target is 23 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00700843 was terminated before completion, sponsored by Ohio State University.
- TERMINATED
- Registry status
- 23 participants
- Enrollment target
Study Summary
Obtain long-term follow-up results for bariatric patients who underwent medical management or surgery for treatment of morbid obesity by Ohio State University Medical Center (OSUMC).
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 23 participants |
| Start Date | 2008-04 |
| Est. Completion | 2011-08 |
Why NCT00700843 stopped before completion
NCT00700843 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 23 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT00700843 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00700843 about?
NCT00700843 is a clinical study titled "Long-Term Follow-up of Ohio State University Medical Center (OSUMC) Bariatric Patients". Obtain long-term follow-up results for bariatric patients who underwent medical management or surgery for treatment of morbid obesity by Ohio State University Medical Center (OSUMC).
What is the current status of trial NCT00700843?
This trial is currently terminated. The enrollment target is 23 participants. The study started on 2008-04. Estimated completion is 2011-08.
Who is sponsoring clinical trial NCT00700843?
This trial is sponsored by Ohio State University, which has 552 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03616041 · 23 participants
Capsule Endoscopy for Severe Hematochezia
- NCT04348747 · 23 participants · Phase 2
Dendritic Cell Vaccines Against Her2/Her3 and Pembrolizumab for the Treatment of Brain Metastasis From Triple Negative Breast Cancer or HER2+ Breast Cancer
- NCT04587687 · 23 participants · Phase 2
Brentuximab Vedotin and Bendamustine for the Treatment of Relapsed or Refractory Follicular Lymphoma
- NCT04715022 · 23 participants · Phase 1
Sympathetic-vascular Dysfunction in Obesity and Insulin Resistance (Vitamin C Study)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia